Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

18.22
-0.6000-3.19%
Volume:365.63K
Turnover:6.80M
Market Cap:1.63B
PE:-7.26
High:19.02
Open:19.01
Low:18.20
Close:18.82
52wk High:25.59
52wk Low:12.99
Shares:89.30M
Float Shares:80.30M
Volume Ratio:0.51
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5100
EPS(LYR):-3.2949
ROE:-255.93%
ROA:-18.67%
PB:107.76
PE(LYR):-5.53

Loading ...

Micron Technology Hits Record High on Strong Earnings Outlook, Goldman Sachs Bullish

Deep News
·
Apr 23

Syndax Pharmaceuticals (SNDX) Receives a Buy from Barclays

TIPRANKS
·
Apr 21

Morgan Stanley: Why Storage Stocks Offer Superior Risk-Reward Over CPU Investments

Deep News
·
Apr 21

Assessing Syndax Pharmaceuticals (SNDX) Valuation After A 110% One Year Return

Simply Wall St.
·
Apr 19

Memory Chip Price Surge Impacts Consumer Electronics: Meta Increases Quest VR Headset Prices by Up to $100

Stock News
·
Apr 17

Is It Too Late To Consider Syndax Pharmaceuticals (SNDX) After A 116% One-Year Surge?

Simply Wall St.
·
Apr 15

Top 20 US Stocks by Trading Volume on April 14: Syndax Reaches New High, Year-to-Date Gain Exceeds 300%

Deep News
·
Apr 14

HBF Commercialization Accelerates: Sandisk to Launch Pilot Line in Second Half, Mass Production by Next Year

Deep News
·
Apr 13

Your Stock Just Doubled. What to Do Now. -- Barrons.com

Dow Jones
·
Apr 07

Syndax grants inducement stock options for up to 228,500 shares to new hires

Reuters
·
Apr 04

Is It Time To Reassess Syndax Pharmaceuticals (SNDX) After An 84% One Year Share Price Jump

Simply Wall St.
·
Apr 02

Syndax Pharmaceuticals Is Maintained at Buy by Goldman Sachs

Dow Jones
·
Apr 02

Micron, Other Memory Stocks Surge. Markets Are Back in Risk-On Mode. -- Barrons.com

Dow Jones
·
Apr 02

Syndax price target raised to $34 from $28 at Goldman Sachs

TIPRANKS
·
Mar 31

Jefferies Keeps Their Buy Rating on Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
Mar 30

Mizuho Securities Sticks to Their Buy Rating for Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
Mar 30

Assessing Whether Syndax Pharmaceuticals (SNDX) Still Looks Undervalued After Its Recent Strong Run

Simply Wall St.
·
Mar 15

Syndax Pharmaceuticals Is Maintained at Overweight by JP Morgan

Dow Jones
·
Mar 10

U.S. RESEARCH ROUNDUP-Dow, Oracle, Shopify

Reuters
·
Mar 09

Syndax Pharmaceuticals Inc : JP Morgan Raises Target Price to $45 From $33

THOMSON REUTERS
·
Mar 09